Retatrutide10mg
$160.00
In stock
Choose quantity — bulk discounts
Triple-agonist (GLP-1/GIP/glucagon) research peptide.
Retatrutide is a next-generation triple receptor agonist that acts simultaneously on the GLP-1, GIP, and glucagon receptors. It is studied in metabolic research for its effects on appetite signaling, energy expenditure, and glucose and lipid regulation. Supplied as a lyophilized powder for laboratory research use only.
Retatrutide is a next-generation research peptide that acts as a triple agonist at the GLP-1, GIP, and glucagon receptors simultaneously. By engaging all three metabolic pathways at once, it is one of the most closely watched compounds in weight-management and metabolic research.
Key information and effects studied: - Investigated for strong appetite regulation and reduced food intake. - Studied for increased energy expenditure via glucagon-receptor activity. - Examined for improvements in blood-sugar and insulin sensitivity. - Researched for favourable effects on lipid and cholesterol profiles. - Studied for significant body-composition and fat-loss outcomes.
Third-party tested
Independently verified certificate of analysis · Batch CP2565C60 · Jun 24, 2026
Research use only. Not for human or veterinary consumption. Submit an order request and we'll reach out to confirm availability and pricing.
Note: vial caps are subject to change and may not be white.